Article Text

S121 Co-morbidity and Pneumonia Risk in COPD Patients: A Population Database Analysis of Primary Care Patients
  1. N Williams1,
  2. NA Coombs2,
  3. L Rigge3,
  4. L Josephs2,
  5. M Johnson4,
  6. DM Thomas2,
  7. TMA Wilkinson5
  1. 1Southampton NIHR Respiratory Biomedical Research Unit, University Hospital Southampton NHS Foundation Trust, Southampton, UK
  2. 2Primary Care and Population Sciences, University of Southampton, Southampton, UK
  3. 3Department of Respiratory Medicine, University Hospital Southampton NHS Foundation Trust, Southampton, UK
  4. 4NIHR CLAHRC Wessex Methodological Hub, University of Southampton, Southampton, UK
  5. 5Academic Unit of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK


Background Co-morbidities are common in COPD and have been associated with poorer clinical outcomes. Furthermore, patients with COPD are at an increased risk of developing Community acquired pneumonia (CAP). We investigated the impact of concurrent co-morbidity on the risk of developing CAP, in a cohort of COPD patients identified from the Hampshire Health Record analytical database, a local NHS database containing anonymised primary and secondary care records.

Methods Patients defined as having COPD, had a diagnostic Read code (classification of clinical terms for electronic information coding) in their primary care record at any time prior to 1st January 2010 and were aged ≥40 years at the start of the study period. Using clinician-coded diagnoses, CAP episodes which occurred over a 1-year period from the 1st January 2010 were identified using Read and ICD-10 code lists and were defined as taking up to 70 days to resolve. Listed co-morbidities were based on coded entries at any time prior to 1st January 2010.

Results Included were 6707 patients with a complete history in 2010 and valid data for all variables considered in the analysis. 55% of patients were men and 36% were current smokers, the mean age was 70 years. 189 patients (2.8%) had at least one CAP episode during 2010. Compared to patients without CAP, patients with CAP were more likely to have ischaemic heart disease (IHD p = 0.005), congestive heart failure (CHF p = 0.021), hypertension (p = 0.017), cerebrovascular disease (CVD p < 0.001), dementia (p < 0.001), and bronchiectasis (p = 0.001). Using logistic regression and controlling for potential confounders, CVD and dementia were independent risk factors for CAP (p = 0.009 and 0.007, respectively), while bronchiectasis trended towards significance (p = 0.073) (Table 1).

Abstract S121 Table 1

Co-morbidities associated with CAP occurrence in COPD

Conclusion In this large population database analysis, CVD and dementia were identified as being independently associated with an increased risk of CAP. Oro-pharyngeal dysfunction in CVD and use of sedative medications in dementia, may contribute to these findings. Further analysis of the complete cohort, over the full 5-year observation period will allow the formulation of robust conclusions about the important factors of CAP risk in COPD, including the impact of pharmacotherapy, blood markers and functional parameters.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.